Friday, April 5, 2024

Weed Doesn’t Smoke the Same Without Others

I don’t smoke weed all day, every day, but there was a time that I did. When I got my first job on the cannabis beat more than a decade ago, I elevated my endocannabinoid system all the time simply because I could smoke, dab, and eat weed all the time. It was a novelty to be high with my co-workers, my boss, people I was interviewing for an article. But when the pandemic took our hands off the wheel of life just about as recklessly as a self-driving car on the streets of San Francisco, it limited access to the physical presence of other people. And, as it turns out, not only do we need in-person connections to thrive, when it comes right down to it, weed just doesn’t smoke the same without others. 

Puff, Puff, Pass

I’m not saying you can’t get higher smoking cannabis alone. I’m arguing that smoking with someone else will always be better. That’s true because cannabis is a connector, and the most transparent public display of that happens each year on 4/20. 

The legend of the adventures of a group of teenage boys meeting up at 4:20 p.m. to search for a cannabis grow is embedded into the lore of cannabis culture forever. Fueled by “lids of fresh green smoke” and driving a ’66 Chevy Impala along the rocky, forested, and wild seashore of the California coastline in Marin County, the adventure tales of the “Waldos” reached the world through articles written by High Times impresario Steve Hager. 

That’s why writing about 4/20 for High Times is such a sacred act—this magazine is a critical player in establishing the history of 4/20. What started as a “safari” searching for a patch of weed with a treasure map by a group of high school friends has become the world’s largest smoke sesh.

Pot the Planet!

Smoking weed at home alone isn’t nearly as fun as smoking it with others. Without the ability to share cannabis safely and freely, I started smoking less. I’m still adjusting to working outside of an office and many days are lonelier that I like to admit.

But with more and more weed events happening, I’m ramping up my social cannabis routine again. The upcoming holiday this month, 4/20, is something the cannabis community celebrates all together. It unites us, and—especially as we roll out of the acute danger of COVID-19—it is vitally essential to our mental health and well-being that we gather to show unity. I want to see other people and smoke their weed. I want to make new friends through weed. Together, we can all get higher!

This year, if you are smoking cannabis in public squares and parks with us on 4/20, I want to let you know you are helping to light a fire by lighting your fire. And this blaze we are building through blazing together is fueling increased access to cannabis all over the planet. 

The Freedom of the Flower

On the flip side of its social energy, solo cannabis smoke sessions can ignite introspective experiences. This can be a good thing, but I’m guessing most of us could use more of the opposite in these post-pandemic times.

The flower is freeing! When we combine being high with positive social experiences shared with fellow weed enthusiasts, we can pause the thoughts in our head for a while. We can open our minds to new experiences. 

As the risks around sharing a smoke diminish, I’m taking off my mask and finally feeling more comfortable social situations. Through visits to social cannabis clubs in cities like Barcelona and San Francisco, I’m remembering how fun it is to smoke with other people around. Still, when I talk about these places with non-smokers, they often assume they are dangerous. The negative stigmas around these social smoke spaces continue, so sharing these places with others is essential. This year, my mom wanted me to take her to a weed lounge for her 73rd birthday and, when I did, she was able to see how normal and natural it is to smoke cannabis in a club. We bought a pack of pre-rolls and sat by the window on a sunny San Francisco afternoon. Afterward, she told me how much safer she felt not trying to hide away in some dark alley smoking on the street.

Opening up new people to the weed lounge experience helps the cannabis freedom cause. The dream is that one day, smoking a joint at a club might be as typical of an experience as ordering a beer at a bar. It certainly would be a lot healthier.   

The Cultivators

The best part of cannabis is the people it brings into your life. The history of this plant is indeed a history of the community around it; it’s a history of the community cultivators. 

Building relationships through the guidance of this plant has greatly contributed to an increase in positive moments in my life. Cannabis brings us together, but the greatest reward is the experience of spending time with others.

Here’s wishing you and yours a happy high holiday. I hope however and wherever you spend your 4/20, you get to do it together with your friends and family. 

The post Weed Doesn’t Smoke the Same Without Others appeared first on High Times.



source https://hightimes.com/weirdos/weed-doesnt-smoke-the-same-without-others/

Thursday, April 4, 2024

Todo lo que Necesitas Saber Sobre el Mercado de Cannabis en Alemania: Cambios, Tamaño y Principales Actores

Nota por Nicolás José Rodríguez publicada originalmente en El Planteo. Más artículos por El Planteo en High Times en Español.

Síguenos en Instagram (@El.Planteo) y Twitter (@ElPlanteo).

El analista Pablo Zuanic, de Zuanic & Associates, esboza el potencial transformador de la nueva legislación en el sector del cannabis medicinal en Alemania y prevé un crecimiento del mercado desde una base de 28.000 pacientes en 2023 hasta un valor de EUR 1.700 millones en 2025.

Zuanic subraya la realidad matizada que subyace a la “legalización” del cannabis en Alemania, un enfoque gradual y por fases hacia la plena legalización.

Contenido relacionado: Acciones de Cannabis se Preparan para el Nuevo Mercado de Alemania: ¿Quiénes Llevan la Delantera?

La fase inicial permite la posesión, el cultivo doméstico y los clubes sociales, aunque la venta al por menor sigue estando prohibida, lo que plantea riesgos y beneficios potenciales.

Una segunda fase especulativa podría introducir la venta en determinadas zonas. Ahora, surge una pregunta para los inversores: ¿qué impulsa este aumento previsto en el mercado alemán de la marihuana medicinal y cómo cambiará el número de usuarios de cannabis medicinal que pagan en efectivo?

Principales beneficiarios de la oleada

Las previsiones de Zuanic se basan en la hipótesis de que el 1% de los cerca de 85 millones de habitantes de Alemania se convertirán en usuarios de marihuana terapéutica, lo que supone un fuerte aumento respecto al 0,03% actual.

Señala que el acceso más fácil y los precios más bajos, facilitados por las clínicas y farmacias en línea, junto con el nuevo panorama normativo, son los principales motores de este crecimiento.

“El cannabis medicinal ya era legal a nivel federal en Alemania, lo que facilitó la cotización en NASDAQ de los LP canadienses debido a sus actividades en Alemania. Los recientes cambios legislativos han facilitado a los médicos la prescripción de cannabis, ya que el cannabis medicinal se ha eliminado de la lista de estupefacientes, agilizando el proceso de prescripción”, escribió Zuanic.

Contenido relacionado: Legalización del Cannabis en Alemania: ¿Por qué Aurora y Tilray Están Mejor Posicionadas?

También identifica a los gigantes del cannabis canadiense Aurora ACB y Tilray TLRY como bien posicionados para beneficiarse del esperado auge, dados sus fuertes lazos de exportación con Alemania.

Aurora es reconocida por liderar el mercado en efectivo, mientras que Tilray destaca por su dominio en el sector reembolsado.

Curaleaf International Holdings Limited, propiedad parcial de Curaleaf CURLF, con su filial alemana Four20 Pharma, está dispuesta a aprovechar sus conexiones, abasteciéndose de productores canadienses y de otros países.

“Entre los operadores multiestatales estadounidenses, una filial de Curaleaf, Curaleaf International Holdings Limited (68,5% propiedad de Curaleaf; los propietarios del otro 31,5% no han sido revelados) posee un importador alemán (Four20 Pharma), que se abastece de productores canadienses y de otros países”, escribió Zuanic.

Destacó otras entidades, como la mayor farmacia en línea del sector privado, Grunhorn, Little Green Pharma, con suministro desde Dinamarca, y el productor nacional de marihuana medicinal Demecan.

Clubes sociales de cannabis en Alemania

“Los adultos podrán unirse a ‘clubes sociales de cannabis‘ (de hasta 500 miembros) en los que los socios organizarán y cultivarán cannabis para consumo personal, distinto del cultivo doméstico, con un límite de extracción de hasta 50 gramos al mes (30 gramos para quienes tengan entre 18 y 21 años). Las cuotas de los socios cubrirán los costes del club, y los individuos sólo podrán unirse a un club”, señaló Zuanic.

Contenido relacionado: Cannabis vs Cerveza: ¿Cuál Es el Verdadero Negocio en Alemania?

“Creemos que los clubes pueden tener un impacto más significativo en el mercado ilícito que afectar al mercado existente de marihuana medicinal, ya que la ley no permite a los productores de cannabis existentes apoyar o asociarse con estos clubes”, concluyó.

Vía Benzinga, traducido por El Planteo

Más contenido de El Planteo:

The post Todo lo que Necesitas Saber Sobre el Mercado de Cannabis en Alemania: Cambios, Tamaño y Principales Actores appeared first on High Times.



source https://hightimes.com/espanol/mercado-cannabis-alemania-cambios/

San Francisco Set To Host Inaugural Weed Week

The city-sanctioned version of the famous 4/20 Hippie Hill event in San Francisco has been canceled, but it’s not the end of 4/20 celebrations in San Francisco. SF Weed Week, will feature a variety of events beginning with an art opening featuring cannabis mylar art on April 5 and a schedule of events running April 13-21. Instead of just one day of celebration, the event spans an entire week of all things cannabis, featuring cultivators and breeders at cannabis lounges throughout the city and unique strain premiers, such as releases of Rainbow Belts, Blue Lobster, Pink Jesus, Chikitaz, The Butcher, Sherb Haze, and Peppermint Sleighride.

SF Weed Week creator David Downs is an award-winning cannabis journalist and author. Downs is the senior editor at Leafly and the former cannabis editor at the San Francisco Chronicle. According to the event website, Downs created SF Weed Week after thinking about what an event like SF Beer Week would be like if it was cannabis-themed instead. 

“Weed growers are rock stars, and strains are celebrities,” Downs said through a press release. “I want to give these strain releases the same rock star treatment that album releases get at Amoeba Records. And we’re going to. It’s going to be dope.”

While SF Beer Week features unique new beer varieties and flavors, SF Weed Week boasts strain releases in participating lounges, including Mission Cannabis Club, Meadow, SPARC, Moe Greens, Solful, The Vapor Room, and Flore. 

Ali Jamalian, owner of Sunset Connect, is a founding advisor of SF Weed Week who is proud to be a part of an event that puts the spotlight on San Francisco weed. 

“San Francisco’s cannabis culture has so much to offer,” Jamalian said in a statement. “It only makes sense to showcase the cannabis epicenter of the world in a week-long celebration spread across the city with an array of amazing events and activations. All for free of course.”

Especially in the wake of the cancellation of this year’s Hippie Hill event, fellow founding advisor Ben Grambergu, director at 7 Stars Holistic Healing Center, feels that SF Weed Week offers an alternative celebration that lifts up the community. 

“The organizers of Hippie Hill deserved a break, and SF Weed Week is here to extend the celebration across the entire city with the best cultivators in the world sharing their gift with the most dedicated enthusiasts in the world,” Grambergu said. “Look, the Bay Area has and always will be an epicenter of cannabis culture. SF Weed Week is proving to the doom loop haters that the scene is thriving. With a week full of incredible activations, world-class cannabis, and meet and greets with the rockstars who produced it; this event has something for everyone.”

The post San Francisco Set To Host Inaugural Weed Week appeared first on High Times.



source https://hightimes.com/events/san-francisco-set-to-host-inaugural-weed-week/

Wednesday, April 3, 2024

Naropa University Offering Minor in Psychedelics Studies

Officials at Naropa University in Boulder, Colorado announced last week that the college will offer a minor in psychedelics studies to prepare students for careers related to the class of drugs, which show great therapeutic potential. The new program, which is slated to launch in the fall, is designed to give students a humanities and social science approach to studying psychedelics.

The new minor was created for students who wish to study the historical and current applications of psychedelics and other natural medicines. The program will also explore the growing field of psychedelic therapy, which has the potential to treat a number of serious mental health issues including depression, post-traumatic stress disorder, anxiety and substance misuse disorders. 

The Bachelor of Arts minor in Psychedelics Studies entails a total of 12 course credits earned from classes such as Herbal Medicine and Theories of Psychedelic Assisted Therapies. In addition to exploring the clinical applications of psychedelic medicines, the curriculum “emphasizes religious and ceremonial contexts, cultural practices, policy implications and healing justice frameworks,” the university explained last week.

“Psychedelic minor graduates will be well prepared for a career in psychedelic-assisted therapy, with both Naropa University’s rigorous academic education and our singularly unique contemplative pedagogy woven throughout the curriculum,” Naropa University president Charles G. Lief, J.D. said in a statement about the new program. “Naropa is a higher education leader when it comes to incorporating justice, equity, anti-oppression, and understanding lineage and indigenous community relationships with plant medicines.” 

Naropa University was founded in 1974 by Tibetan Buddhist teacher Chögyam Trungpa Rinpoche. The institution’s name and inspiration are derived from the teachings of the 11th-century Indian Buddhist sage Naropa. The university is internationally known for its unique educational program, which integrates Eastern knowledge and traditions with traditional Western scholarly pursuits.

“This minor will integrate well with the range of undergraduate majors offered at Naropa including Psychology, Interdisciplinary Studies, Art Therapy, Religious Studies, Creative Writing and Literature, Yoga Studies or Visual Arts,” Lief added. “Several of these majors have an online option, making the new minor very accessible to students in North America and beyond.”

New Opportunites for Careers in Psychedelics Therapy

The new minor in Psychedelics Studies will serve as a foundational curriculum for undergraduate students to learn and apply the mindfulness and compassion skills that are key to successful psychedelic therapy. Scholarships are available to support equitable access for students with fewer economic resources to increase opportunities for those who may be from marginalized communities or underserved geographic locations in order to create a more diverse field of practitioners.

“The emerging field of legal psychedelic-assisted therapy will require trained facilitators to meet the demand for these services,” said Joseph Harrison, M.S., executive director of the Naropa Center for Psychedelic Studies (NCPS). “Naropa’s psychedelic studies minor will provide primary education for students interested in working in this emerging field. We are creating a pathway for students that begins with the BA Psychedelic Studies Minor. Serious students can further their learning through Naropa’s Graduate School of Counseling Psychology and then our postgraduate training programs to become licensed practitioners in states such as Colorado and Oregon.”

Clinical research and other studies into psychedelics such as LSD, psilocybin and MDMA have shown that the drugs have potential therapeutic benefits, particularly for serious mental health conditions such as depression, PTSD, substance misuse disorders and anxiety. Early last year, a California biopharmaceutical company announced positive results from a clinical trial testing MDMA as a treatment for PTSD. Research published in the peer-reviewed journal JAMA Psychiatry in 2020 found that psilocybin-assisted psychotherapy was an effective and quick-acting treatment for a group of 24 participants with major depressive disorder. A separate study published in 2016 determined that psilocybin treatment produced substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.

The U.S. Department of Health and Human Services projects that the Food and Drug Administration will eventually approve MDMA and psilocybin mental health treatments, according to a letter from the department in May 2022. In 2017, the FDA granted MDMA-assisted therapy Breakthrough Therapy designation, indicating that the therapy is a significant improvement over existing treatments. Last month, the agency took similar action with an LSD drug that is being studied as a treatment for anxiety.

“The minor in psychedelic studies integrates existing contemplative coursework across diverse disciplines with the latest scholarship on psychedelic studies,” said Betsy Gonzalez Blohm, dean of Naropa College and the Graduate Collective. “Contemplative pedagogy centering diverse perspectives to support inner and outer transformation is core to Naropa’s mission, and offering academic study about the history, policy and current research on psychedelics supported by our unique approach to education is an extension of that mission.”

The post Naropa University Offering Minor in Psychedelics Studies appeared first on High Times.



source https://hightimes.com/psychedelics/naropa-university-offering-minor-in-psychedelics-studies/

Tuesday, April 2, 2024

Office of the Pardon Attorney Requests Funds To Tackle Pardon Applications

The Office of the Pardon Attorney (PARDON), which operates under the U.S. Department of Justice (DOJ), recently published its FY 2025 President’s Budget Submission. PARDON is responsible for carrying out instructions related to the executive clemency process, which includes reviewing and investigating clemency applications, as well as issuing recommendations to the president. 

For next year, PARDON is requesting $12,568,000 in funds, which would go toward funding 40 additional positions (including 26 attorneys) “to achieve its mission of advising and assisting the president in the exercise of the executive clemency power conferred to him by Article III, Section 2 of the Constitution.”

Among various listed upcoming challenges is the recent increase in clemency applications. The report stated that prior to FY 2014, and especially during the 1990s, PARDON only included 11 staff positions, which was enough to tackle the 600 applications that would come in annually. However, between FY 2012-FY 2023, PARDON received 52,065 applications.

PARDON is hoping to increase its resources further due to this increase in applications specifically related to cannabis. “PARDON expects to continue to receive incoming clemency cases, both pursuant to ordinary case submissions—which historically increase in proximity to presidential elections—and to the President’s October 2022 and December 2023 Proclamations pardoning individuals convicted of simple possession of marijuana,” the report stated.

The report continued to explain the status of the agency, noting that as of February 2024, only 171 pardon certificates were issued, and a total of 184 since 2023. PARDON explained that certificates are issued only after a thorough case investigation has been conducted.

However, with an increase in funds, PARDON seeks to increase the rate at which cases are conducted. “The FY 2025 request will allow PARDON to both continue to review and address pending clemency cases, receive new ones, evaluate capital cases, and process the influx of submissions pursuant to the two Presidential Proclamations on marijuana,” PARDON stated.

Furthermore, PARDON is setting a goal of increasing its “Percentage of marijuana certificates issued to eligible recipients within 30 days of application receipt,” to 80% in FY 2024.

President Joe Biden initially announced that he would be pardoning federal cannabis prisoners in October 2022, and also promised that the White House would “review expeditiously” the current classification of cannabis. The DOJ began to conduct investigations for pardon applications in March 2023, but didn’t begin issuing pardon certificates until after September 2023 under Biden’s order. It also held a public comment period between March 2023 and August 2023, in order to gather information on how to “expeditiously” act on Biden’s order to grant pardons related to simple cannabis possession.

In December 2023, Biden pardoned 11 people who held non-violent cannabis convictions and expanded his pardon initiative to include offenses that occurred on federal property. “America was founded on the principle of equal justice under law. Elected officials on both sides of the aisle, faith leaders, civil rights advocates, and law enforcement leaders agree that our criminal justice system can and should reflect this core value that makes our communities safer and stronger,” Biden said. “That is why today I am announcing additional steps I am taking to make the promise of equal justice a reality.”

Much more recently in March, Vice President Kamala Harris hosted a weed policy reform summit where she said that the current schedule of cannabis is “absurd” and called for it to be rescheduled as soon as possible. The summit was attended by rapper Fat Joe, recently pardoned advocate Chris Goldstein, and Kentucky Gov. Andy Beshear. “I hope everyone can recognize the importance of Vice President Harris calling to “legalize marijuana” in a room that Richard Nixon built = huge,” Goldstein posted on X.

Amidst a shift in promises for cannabis rescheduling or a lifting of federal prohibition, legislators are still calling on Biden to commute the sentences of all federal cannabis prisoners. A total of 36 legislators signed a letter to Biden on March 14, inquiring about Biden’s 2020 campaign pledge to decriminalize cannabis on a federal level. “Until the day Congress sends you a marijuana reform bill to sign, you have a unique ability to lead on criminal justice reform and provide immediate relief to thousands of Americans,” the letter stated. “It is inconsistent for the federal government to keep punishing individuals for violating a ban that it does not actually support and that an overwhelming majority of Americans oppose on a bipartisan basis… We ask that you commute the prison sentences of all individuals who are incarcerated for federal marijuana offenses.”

Some governors are continuing to push for cannabis-related pardons, such as Massachusetts Gov. Maura T. Healey. In mid-March Healey announced her plans to pardon cannabis misdemeanors. She said it “would be the most comprehensive action by a governor since President Joe Biden pardoned federal marijuana possession convictions and called on governors to take similar actions in their states,” and that it “could impact hundreds of thousands of people.”

The post Office of the Pardon Attorney Requests Funds To Tackle Pardon Applications appeared first on High Times.



source https://hightimes.com/news/office-of-the-pardon-attorney-requests-funds-to-tackle-pardon-applications/

Zimbabwe Farmers Swap Corn for Hemp Farming

Farmers in Zimbabwe are pivoting from the country’s traditional staple crops like corn to a new lucrative crop—hemp production. Leaders in the country, however, are more worried about any disruptions to food security locally than the potential economic boon hemp will likely bring to the country.

Agriculture contributes about 18% to Zimbabwe’s total gross domestic product (GDP), and maize or corn is the country’s staple crop and accounts for a substantial proportion of the lion’s share of fertilizers that are used, the Zimbabwe Food and Agriculture Organization reports. Corn crops are followed by millet and sorghum, in terms of prevalence.

The country also adopted a unique hemp program compared to other countries. In February 2023, Zimbabwe increased the THC limit for industrial hemp from 0.3% to 1%, making significant changes for the African country’s hemp industry. That changes everything, as even 1% THC is enough to allow for products with low psychoactive effects. International companies have taken note and are utilizing growth through Zimbabwean hemp.

The rapid changes in Zimbabwe’s economy is promising but it also creates a few new concerns. ZimEye reports that the country’s hemp industry is governed by the country’s Agricultural Marketing Authority (AMA), and the shift into hemp production signals a new era for Zimbabwe’s economy, which has historically been rooted in food production. 

However, this pivot towards industrial hemp cultivation raised concerns over the potential negative impacts on the nation’s food security, challenging Zimbabwe’s agricultural legacy: The 1975 UN World Book records highlighted Zimbabwe—then called Rhodesia—as having the fastest-growing crop economy.

International interest in Zimbabwean hemp is increasing. Zimbabwe has exported over 8,000 tons of hemp to countries such as Poland, Switzerland, and Germany. Plantiqua Hemp, a Poland-based company, for instance, to enhance the quality and marketability of Zimbabwean hemp.

This makes AMA agribusiness director Jonathan Mukuruba optimistic about this new sector that’s growing in strength. “The future of industrial hemp in Zimbabwe looks very promising… with a growing interest in the sector, Zimbabwe is on track to emerge as a regional leader in industrial hemp production,” Mukuruba said.

Zimbabwe’s poverty rate hit nearly 40% in 2019, which is why food security is crucial in any decision for local leaders. “Poverty” is defined in the country as people who make less than $2.15 per day.

 “The challenge lies in balancing the cultivation of crops for industrial purposes with the imperative to ensure food security,” stated Dr. Frank Magama, CEO of Kutsaga Research Station. “As we explore the potential of hemp, we must also consider our longstanding tradition of food production and the critical importance of maintaining food security.”

Kutsaga Research Station is conducting research to identify hemp varieties suitable for Zimbabwe. 

Zimbabwe’s Shifting Economy and Hemp

That’s changing quickly in the African country as nearly all forms of cannabis were illegal prior to changes made in 2018. 

In 2018, Zimbabwe became the second nation in Africa to legalize medical cannabis and cannabis production for medical and scientific purposes. Since then, Zimbabwe officials registered over sixty entities in the hemp production, trade, and research sectors since the market took off in 2018.  In 2019, Zimbabwe abolished its ban on cannabis cultivation, which set the stage for the country’s farmers to begin cultivating industrial hemp to export. That same year, the country issued the first license to a medical cannabis company to begin cultivation.

In May 2022, Zimbabwean President Emmerson Mnangagwa commissioned a $27 million medical cannabis farm and processing plant to be run by Swiss Bioceuticals Limited in West Province, Zimbabwe.

The Medicines Control Authority of Zimbabwe said on July 26, 2022 that it would begin accepting applicants from cannabis and hemp producers, manufacturers, importers, exporters, and retail pharmacists, in a seismic shift away from tobacco.

Higher THC caps make the country’s hemp unique.

Zimbabwe Independent reported that the THC level increase makes significant changes for CBD manufacturers, who will now be able to produce the entourage effect combined with other cannabinoids. 

The amended bill, called the Criminal Law (Codification and Reform) Amendment Bill, 2002 is proposing the amendment of section 155 of the Criminal Law (Codification and Reform) Act [Chapter 9:23] (hereinafter referred to as “the Act”) to remove industrial hemp from the list of dangerous drugs.

“By the insertion of the following definition,” the bill reads, “‘Industrial hemp’ means the plant cannabis sativa L and any part of that plant, including the seed thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts and salts of isomers, whether growing or not with a delta-9-tetrahydrocannabinol concentration of not more than one per centum on a dry weight basis.”

With looser restrictions on hemp farming, the plant could replace maize or corn eventually as the country’s next staple crop.

The post Zimbabwe Farmers Swap Corn for Hemp Farming appeared first on High Times.



source https://hightimes.com/news/zimbabwe-farmers-swap-corn-for-hemp-farming/

Massachusetts Lawmakers Consider Psychedelics Therapy Legalization Bill

Massachusetts legislators held a joint legislative committee hearing last week to consider an initiative to legalize the therapeutic use of natural psychedelics. At the hearing, lawmakers heard from both supporters and opponents of the proposal, which can be approved by the legislature or referred to voters to decide the issue this November.

The proposed ballot measure is supported by Massachusetts for Mental Health Options (MMHO). The group is affiliated with New Approach, a political action committee that supported successful bids to legalize psychedelics in Oregon and Colorado. If passed, the proposed ballot measure would legalize “naturally occurring” psychedelics such as psilocybin mushrooms, peyote (mescaline), and ibogaine for consumption in “therapeutic settings through a regulated and taxed system.”

MMHO has already submitted nearly 100,000 signatures on petitions to support the ballot measure, sending it to the state legislature for consideration. If lawmakers do not approve the measure by May 1, supporters will be given until July 3 to collect an additional 12,429 valid signatures. If the signature drive is successful, the initiative will be placed on the ballot for the November general election.

Advocates Speak in Favor of Psychedelics Proposal

On March 26, the Massachusetts state legislature’s Special Joint Committee on Initiative Petitions held a hearing on the psychedelics therapy legalization ballot measure (Bill H.255). Emily Oneschuk, a military veteran and MMHO’s grassroots campaign director, told lawmakers about the mental health challenges she faced while serving in the U.S. Navy, including sexual assault, bullying and sexual harassment. After Oneschuk left the Navy, she took psilocybin at a retreat in Jamaica, where the psychedelic compound is legal.

“The whole of my psychedelic experience and the community associated with it has profoundly improved my quality of life,” Oneschuk told the committee, according to a report from the Commonwealth Beacon. “It brought me exactly where I needed to be to become a healthier and happier person.”

Dr. Franklin King, the director of training and education at the Mass General Center for the Neuroscience of Psychedelics and an instructor at Harvard Medical School, researches the effects of psychedelics. He told the joint committee that there is substantial evidence showing that psychedelics have therapeutic value for mental health conditions. He also noted that studies have repeatedly shown that the drugs can be taken by patients safely and effectively.

“The current legal status of psychedelics as dangerous drugs…is egregiously incorrect,” said King. “[For this] class of psychedelics, particularly psilocybin, the medical risks are extremely minimal and potential for abuse is close to zero. Millions of patients who need access to the benefits of psychedelics likely do not require the strict controls of the medical model.”

Franklin continued by saying that the current prohibition of psychedelics is hindering research and denying people with mental health challenges an alternative to less effective drugs.

“The criminalization of psychedelics not only impedes scientific progress, but also denies individuals access to potentially life changing treatments,” King told lawmakers, according to a report from New England Public Media. “We must adopt a more rational approach, one that prioritizes evidence based policies over outdated stigmas and prohibitions.”

Massachusetts Psychiatrists Urge Caution

Not everyone at the hearing, however, was there to support the psychedelics therapy legalization proposal. Dr. Jerrold Rosenbaum, a psychiatrist at Massachusetts General Hospital, told lawmakers “We really don’t know what are the potential harms.”

Rosenbaum agreed with testimony from supporters about the potential benefits of psychedelics. But he also warned about the potential for people to misuse the powerful compounds.

“Psychedelics are not something people can use casually at full doses,” he said in testimony cited by Boston’s NBC News affiliate. “They really require being in a safe place with support for most people.”

The psychiatrist acknowledged similarities between the campaign to legalize marijuana, which succeeded in Massachusetts in 2016 with the passage of a ballot measure that received more than 63% of the vote. But he added that reforming policy governing psychedelic drugs should be approached with more caution.

“The psychedelics are used very intermittently, not continually the way marijuana can be. The effects are much more profound,” he said.

Dr. Nassir Ghaemi, a professor of psychiatry at Tufts Medical Center and the incoming president of the Massachusetts Psychiatric Society, also testified before the committee. He told lawmakers that there has not been enough research on the public health outcomes of legalizing psychedelics.

Democratic Senator Paul Feeney, a member of the legislative committee, noted that psychedelics are already being used recreationally by many people and asked Ghaemi if it would be better if lawmakers adopted regulations governing their use. The witness agreed, but only if the ballot measure is approved in November. Otherwise, he said the legislature should wait until additional research has been completed.

The joint committee will now review the testimony given at the hearing before voting on whether to advance the proposal.

The post Massachusetts Lawmakers Consider Psychedelics Therapy Legalization Bill appeared first on High Times.



source https://hightimes.com/news/massachusetts-lawmakers-consider-psychedelics-therapy-legalization-bill/